“Appropriate Utilization of the Prognostic 40-Gene Expression Profile (40-GEP) Test for Cutaneous Squamous Cell Carcinoma (cSCC) Demonstrated by Clinical Reports and Physician Evaluation of Real-World Cases”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): s21. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1538.